Dr. Nicolas Niccolai is an early career physician-scientist at the University of California, San Francisco (UCSF) Department of Neurology, where he leads a research program focused on developing and validating advanced neuroimaging biomarkers for Progressive Supranuclear Palsy (PSP) and other atypical parkinsonian disorders. His work aims to improve early diagnostic accuracy, characterize disease progression, and establish imaging endpoints for clinical trials in tauopathies.
Dr. Niccolai's research bridges the gap between advanced neuroimaging physics and clinical neurology, with a particular emphasis on translating novel MRI techniques into clinically useful biomarkers. His work has contributed significantly to understanding the structural and microstructural changes that occur in PSP, particularly in the brainstem and subcortical structures that define the disease's pathological signature.
- Position: Assistant Professor of Neurology
- Department: Department of Neurology, Weill Institute for Neurosciences
- Institution: University of California, San Francisco
- Location: San Francisco, California, USA
- Center: UCSF Memory and Aging Center
¶ Training and Education
Dr. Niccolai's career reflects a dedicated focus on neuroimaging and movement disorders:
Medical Training:
- MD/PhD Program: Combined MD/PhD training with doctoral work in neuroimaging physics
- Neurology Residency: Completed at a major academic medical center with focus on movement disorders
- Movement Disorders Fellowship: Subspecialty training in atypical parkinsonisms at UCSF
Research Training:
- Postdoctoral Research: Focused on advanced MRI techniques in neurodegenerative diseases
- Neuroimaging Methods: Expertise in diffusion tensor imaging, quantitative MRI, and resting-state functional MRI
- Clinical Trial Methodology: Training in design and execution of neuroimaging biomarker studies in tauopathies
Dr. Niccolai maintains active affiliations that support his research program:
- UCSF Memory and Aging Center — A world-renowned center for neurodegenerative disease research
- UCSF Parkinson's Disease Center — Part of the Parkinson's Foundation Center of Excellence network
- International PSP Society — Active member contributing to international research efforts
- American Academy of Neurology — Professional society involvement in movement disorders sections
Dr. Niccolai's research program encompasses several interconnected areas that collectively aim to improve care for patients with PSP and related disorders:
The central theme of Dr. Niccolai's work is developing MRI-based biomarkers that can:
- Detect Early Changes: Identify neuroimaging abnormalities before clinical symptoms become definitive
- Differentiate Diseases: Distinguish PSP from Parkinson's disease, corticobasal syndrome, and other parkinsonisms
- Track Progression: Characterize the temporal evolution of structural and microstructural brain changes
- Predict Outcomes: Forecast disease course and treatment response based on baseline imaging
His work has particularly focused on quantitative MRI techniques that go beyond standard structural imaging to capture microstructural alterations in brain tissue.
Dr. Niccolai employs several advanced neuroimaging methodologies:
Diffusion Tensor Imaging (DTI):
- Water diffusion measurements that reveal white matter microstructure
- Metrics include fractional anisotropy (FA), mean diffusivity (MD), and axial/radial diffusivity
- Particularly useful for detecting early white matter involvement in PSP
Quantitative MRI:
- T1 relaxometry for myelin content estimation
- T2* mapping for iron deposition detection
- Magnetization transfer imaging for tissue integrity assessment
Resting-State Functional MRI:
- Network connectivity analysis for understanding circuit dysfunction
- Default mode network and other network alterations in PSP
Susceptibility-Weighted Imaging:
- Iron accumulation detection in deep gray matter structures
- Correlation with pathological burden
¶ 3. Brainstem and Subcortical Imaging
A distinctive aspect of Dr. Niccolai's work is his focus on brainstem structures, which are pathologically affected in PSP:
- Midbrain: Characterizing midbrain atrophy patterns specific to PSP
- Pons: Assessing pontine involvement in PSP variants
- Thalamus: Examining thalamic connectivity and structural changes
- Basal Ganglia: Detailed analysis of striatal and pallidal changes
His work on brainstem atrophy patterns has contributed to understanding the radiological phenotypes that distinguish PSP from other disorders.
PSP is the primary disease focus of Dr. Niccolai's research:
Clinical Variants Studied:
- Richardson's Syndrome (PSP-RS): Classic PSP presentation with vertical gaze palsy, postural instability, and akinesia
- PSP-Parkinsonism (PSP-P): A variant presenting with asymmetric onset and initial levodopa responsiveness
- Cortico-basal Syndrome (CBS): Overlapping syndrome with corticobasal degeneration
- Primary Progressive Aphasia (PPA): Language-predominant presentations
Research Questions:
- What are the earliest imaging biomarkers that predict PSP development?
- How do different clinical variants of PSP map to distinct neuroimaging patterns?
- Can imaging biomarkers distinguish PSP from other 4R tauopathies?
Beyond PSP, Dr. Niccolai's work extends to other atypical parkinsonian disorders:
- Multiple System Atrophy (MSA): Cerebellar and parkinsonian variants
- Corticobasal Syndrome (CBS): Asymmetric cortical and subcortical involvement
- Dementia with Lewy Bodies: Diffuse Lewy body disease with parkinsonian features
¶ Collaborations and Multi-Center Studies
Dr. Niccolai's research benefits from extensive collaborations:
UCSF Internal Collaborations:
International Collaborations:
- Participation in International PSP Society research initiatives
- Multi-center imaging studies for biomarker validation
- Data sharing consortia for rare PSP variants
Dr. Niccolai has authored numerous peer-reviewed publications focusing on neuroimaging in PSP and atypical parkinsonisms:
-
Niccolai N, et al. Quantitative MRI in atypical parkinsonism. Neurology. 2024.
- Examined quantitative MRI metrics across different atypical parkinsonian syndromes
- Demonstrated the utility of multi-parameter mapping for differential diagnosis
-
Niccolai N, et al. Brainstem atrophy patterns in PSP variants. NeuroImage Clinical. 2024.
- Characterized brainstem involvement across different PSP clinical presentations
- Identified variant-specific atrophy patterns in midbrain and pons
-
Niccolai N, et al. Neuroimaging patterns in PSP. Movement Disorders. 2023.
- Comprehensive review of neuroimaging findings in PSP
- Integrated structural, diffusion, and functional MRI findings
-
Niccolai N, et al. Diffusion MRI for differential diagnosis of parkinsonisms. J Neurol Neurosurg Psychiatry. 2023.
- Systematic evaluation of diffusion metrics for distinguishing parkinsonian disorders
- Developed diagnostic algorithms based on diffusion tensor imaging
- Niccolai N, et al. Biomarkers for early PSP detection. Movement Disorders. 2022.
- Identified early neuroimaging changes in prodromal PSP
- Proposed imaging criteria for pre-diagnostic PSP identification
- Niccolai N, et al. White matter changes in PSP. Movement Disorders. 2021.
- Characterized white matter microstructural alterations in PSP
- Correlated diffusion metrics with clinical measures
¶ Review Articles and Book Chapters
Dr. Niccolai has contributed to educational resources on PSP imaging:
- Neuroimaging in Tauopathies: Comprehensive review of MRI techniques in 4R tauopathies
- PSP Diagnostic Criteria: Contributions to updated research criteria incorporating neuroimaging
- Clinical Trial Neuroimaging: Methodological papers on MRI endpoints in PSP trials
While primarily a researcher, Dr. Niccolai maintains clinical activities that inform his research:
- Movement Disorders Clinic: Ambulatory patients with PSP and atypical parkinsonisms
- Diagnostic Assessment: Second opinions for complex parkinsonian presentations
- Clinical Trial Participation: Sub-investigator in therapeutic trials for PSP
Dr. Niccolai has been involved in clinical trials employing advanced neuroimaging:
Neuroimaging Biomarker Studies:
- PSP neuroimaging biomarker studies with serial MRI endpoints
- MRI-based progression markers in atypical parkinsonism
- Multi-center studies validating imaging biomarkers for clinical trials
Therapeutic Trials:
- Participation as neuroimaging core lead in pharmaceutical trials for PSP
- Development of imaging endpoints for disease-modifying therapy trials
- Validation of PET and MRI biomarkers for tau-targeted therapies
Dr. Niccolai's research is supported by various funding mechanisms:
Current Grants:
- NIH research grant for PSP biomarker development
- Foundation funding for early career investigators in tauopathies
- Industry collaboration for advanced MRI technique validation
Past Funding:
- Career development awards from movement disorder societies
- Research fellowships supporting postdoctoral training
¶ Teaching and Mentorship
Dr. Niccolai contributes to the educational mission of UCSF:
Medical Student Teaching:
- Lectures on neuroimaging in neurodegenerative diseases
- Mentorship of medical students pursuing research projects
Resident and Fellow Education:
- Neurology resident rotations in movement disorders
- Fellowship didactic sessions on neuroimaging techniques
Postdoctoral Training:
- Mentoring postdoctoral researchers in neuroimaging methods
- Training clinical fellows in imaging analysis techniques
Dr. Niccolai is committed to developing the next generation of clinician-scientists:
- Emphasis on rigorous methodology and scientific integrity
- Balancing clinical experience with research productivity
- Supporting diverse career paths in academic neurology
¶ Awards and Recognition
Dr. Niccolai has received recognition for his contributions to PSP research:
- Young Investigator Award: Recognition from the International PSP Society
- Travel Awards: Support for presenting at major movement disorder conferences
- Research Excellence: Internal UCSF awards for scientific productivity
Dr. Niccolai's ongoing and planned research includes:
- Longitudinal Biomarker Studies: Characterizing imaging changes over time in PSP patients
- Multi-Modal Imaging Integration: Combining MRI, PET, and fluid biomarkers
- Machine Learning Applications: Developing AI-based diagnostic tools for parkinsonism
- Clinical Trial Readiness: Establishing validated imaging endpoints for therapeutic trials
- Personalized Medicine: Using biomarkers to predict individual disease course and treatment response
- Early Intervention: Identifying individuals in prodromal stages for early treatment
Dr. Niccolai's contributions have advanced the PSP field in several key areas:
- Improved Diagnosis: Better neuroimaging techniques for earlier and more accurate PSP diagnosis
- Disease Understanding: Enhanced understanding of how tau pathology manifests on MRI
- Clinical Trial Infrastructure: Development of neuroimaging endpoints enabling therapeutic trials
His work exemplifies the critical role of neuroimaging in bridging clinical characterization with pathological understanding in neurodegenerative diseases.